Skip to content

Clinical trials

Overweight trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Austria Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20112
20171
20181
20192
20212
20222
20235
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Active, not recruiting3
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Novo Nordisk A/S5
Green Beat2
Alexandra Kautzky-Willer1
Amgen1
AstraZeneca1
Charite University, Berlin, Germany1
Department of Nephrology Clinic Ottakring Vienna1
Dr. Willmar Schwabe GmbH & Co. KG1
FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight23
Obesity22
Diabetes Mellitus, Type 24
Cardiovascular Diseases3
Prediabetic State3
Renal Insufficiency, Chronic3
Atherosclerosis2
Diabetes Mellitus2
Fatty Liver2
Insulin Resistance2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.